Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer

BACKGROUND: Despite heightened interest in early-onset colorectal cancer (CRC) diagnosed before age 50, little is known on immune cell profiles of early-onset CRC. It also remains to be studied whether CRCs diagnosed at or shortly after age 50 are similar to early-onset CRC. We therefore hypothesized that immune cell infiltrates in CRC tissue might show differential heterogeneity patterns between three age groups (<50 “early-onset”, 50-54 “intermediate-onset”, ≥55 “later-onset”). METHODS: We examined 1,518 incident CRC cases with available tissue data, including 35 early-onset and 73 intermediate-onset cases. To identify immune cells in tumor intraepithelial and stromal areas, we developed three multiplexed immunofluorescence assays combined with digital image analyses and machine learning algorithms, with the following markers: (1) CD3, CD4, CD8, CD45RO (PTPRC), FOXP3 for T cells; (2) CD68, CD86, IRF5, MAF, MRC1 (CD206) for macrophages; (3) ARG1, CD14, CD15, CD33, HLA-DR for myeloid cells. RESULTS: Although no comparisons between age groups showed statistically significant differences at the stringent two-sided α level of 0.005, compared to later-onset CRC, early-onset CRC tended to show lower levels of tumor-infiltrating lymphocytes (P=0.013), intratumoral periglandular reaction (P=0.025), and peritumoral lymphocytic reaction (P=0.044). Compared to later-onset CRC, intermediate-onset CRC tended to show lower densities of overall macrophages (P=0.050), M1-like macrophages (P=0.062), CD14(+)HLA-DR(+) cells (P=0.015), and CD3(+)CD4(+)FOXP3(+) cells (P=0.039). CONCLUSIONS: This hypothesis-generating study suggests possible differences in histopathologic lymphocytic reaction patterns, macrophages, and regulatory T-cells in the tumor microenvironment by age at diagnosis.